Does Rallies show 13F holders for WHWK?

Yes. Rallies tracks hedge fund and 13F ownership data for WHWK, including fund names, share counts, latest tracked quarter, and position changes when available.

Is WHWK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for WHWK. It does not provide personalized investment advice.

WHWK (Whitehawk Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Whitehawk Therapeutics, Inc. Common Stock (WHWK) is a publicly traded Healthcare sector company. As of May 21, 2026, WHWK trades at $4.17 with a market cap of $210.17M and a P/E ratio of -12.68. WHWK moved +4.18% today. Year to date, WHWK is +66.80%; over the trailing twelve months it is +112.06%. Its 52-week range spans $1.39 to $5.50. Analyst consensus is buy with an average price target of $7.33. Rallies surfaces WHWK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns WHWK stock?

Hedge funds tracked by Rallies that own WHWK include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Whitehawk Therapeutics, Inc. Common Stock.

WHWK Key Metrics

Key financial metrics for WHWK
Metric	Value
Price	$4.17
Market Cap	$210.17M
P/E Ratio	-12.68
EPS	$-0.33
Dividend Yield	0.00%
52-Week High	$5.50
52-Week Low	$1.39
Volume	17
Avg Volume	0
Revenue (TTM)	$7.14M
Net Income	$-20.60M
Gross Margin	89.36%

Top Hedge Funds Holding WHWK

Orbimed Advisors holds 4.17M shares of WHWK, changed +0.00% as of Mar 31, 2026.

Latest WHWK News

Whitehawk Therapeutics Raises $87.5M in Private Placement to Fund ADC Pipeline — May 13, 2026
Whitehawk Reports $123M Cash, Advances Phase 1 Trials, Plans HWK-206 IND — May 7, 2026
Whitehawk Finds 100-Fold MUC16 Expression Advantage, Backs HWK-016 Phase 1 — Apr 10, 2026
Whitehawk Therapeutics Details ADC Pipeline Progress and 2028 Cash Runway — Feb 25, 2026

Recent WHWK Insider Trades

Giacobello Scott M. sold 141.60K (~$584.81K) on Apr 16, 2026.
Giacobello Scott M. sold 77.00K (~$297.22K) on Apr 15, 2026.
BALL BRYAN sold 92.46K (~$336.55K) on Apr 14, 2026.

WHWK Analyst Consensus

5 analysts cover WHWK: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.33.

Common questions about WHWK

Who owns WHWK stock?: Hedge funds tracked by Rallies that own WHWK include Orbimed Advisors. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Whitehawk Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for WHWK?: Yes. Rallies tracks hedge fund and 13F ownership data for WHWK, including fund names, share counts, latest tracked quarter, and position changes when available.
Is WHWK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for WHWK. It does not provide personalized investment advice.